Pyoderma gangrenosum with splenic involvement  by AlDossary, Shaikha Jameel et al.
International Journal of Pediatrics and Adolescent Medicine (2016) 3, 78e80HOSTED BY Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.elsevier .com/locate/ i jpamINSTRUCTIVE CASEPyoderma gangrenosum with splenic
involvement
Shaikha Jameel AlDossary a,b,*, Tariq S. AlFawaz b,
Awatif K. AlMutairi ca Dammam University, Department of Pediatrics, King Fahd University Hospital, Khobar, Saudi Arabia
b King Fahad Medical City, Riyadh, Saudi Arabia
c Children Hospital King Fahad Medical City, Riyadh, Saudi ArabiaReceived 27 November 2015; received in revised form 29 February 2016; accepted 24 March 2016
Available online 29 April 2016KEYWORDS
Pyoderma
gangrenosum (PG);
Spleen involvement;
Children* Corresponding author. Dammam
Pediatrics, King Fahd University Hos
Tel.: þ966 503891101.
E-mail addresses: sh.al-dossar
AlDossary), talfawaz@kfmc.med.sa (
kfmc.med.sa (A.K. AlMutairi).
Peer review under responsibility o
pital & Research Centre (General Org
http://dx.doi.org/10.1016/j.ijpam.20
2352-6467/Copyright ª 2016, King Fais
by Elsevier B.V. This is an open accesAbstract Pyoderma gangrenosum (PG) is a non-infectious disease characterized by necro-
tizing, ulcerative, and painful skin. The incidence of PG is approximately 3e10 cases per
million people per year. Pyoderma gangrenosum is rarely observed in children, which accounts
for less than 4%, but it primarily affects adults between the ages of 25 and 54 years old without
gender preference. Here, we present a case report of a 16-month-old toddler diagnosed with
pyoderma gangrenous with splenic involvement. The young age of the patient and extracuta-
neous manifestation are of high interest.
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Pyoderma gangrenosum (PG) is a non-infectious disease
characterized by necrotizing, ulcerative, and painful skinUniversity, Department of
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al Specialist Hospital & Research C
s article under the CC BY-NC-ND[1e3]. The incidence of PG is approximately 3e10 cases per
million people per year [4]. Pyoderma gangrenosum is
rarely observed in children, accounting for less than 4% of
cases, but it primarily affects adults between the ages of 25
and 54 years old without gender preference. [1,2,5,6]
However, the cause of pyoderma gangrenosum is poorly
understood. Some researchers attributed the cause to
dysfunction in the immune system [7,8]. In most cases, PG
manifests as small lesions that become larger and spread.
Pyoderma gangrenosum can be subcategorized as ulcera-
tive, bullous, pustular, and vegetative [9,10]. A PG diag-
nosis is usually of exclusion, as there are no specific criteria
to confirm diagnosis. Using systemic steroids is the most
effective treatment of PG in children [1,2].entre (General Organization), Saudi Arabia. Production and hosting
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2 US abdomen showing splenic abscess.
Pyoderma gangrenosum 79Clinical information was retrieved via a retrospective
review of medical records to determine clinical
manifestation.
2. Case
A 16-month-old girl with no previous medical history pre-
sented with a fever associated with recurrent feet and
hand abscesses that rapidly ruptured and formed deep
ulcers. Skin examination at the ulcerous stage revealed
multiple large tender necrotic oval ulcers with a purulent
base and sharply defined violaceus undermined edges in
the hands and feet (Fig. 1). Initial work-up showed
leukocytosis with predominant neutrophils, an ESR of
83 mm/h and a CRP of 29.7 mg/L. Abscesses did not
respond to antimicrobial therapy. Abdominal US revealed
splenic abscess measuring 10.47  10.82 cm (Fig. 2). The
culture from both skin lesions and the splenic lesion were
negative, and the histopathology demonstrated charac-
teristics of PG. However, all immune tests were within
normal ranges. The patient was started on oral predniso-
lone (2 mg/kg/day) for two weeks and showed a good
response, in which the fever resolved and all of the lesions
healed.
3. Discussion
Pyoderma gangrenosum is neutrophilic dermatosis that is
destructive in nature with unknown causes. More than half
of patients with PG develop the disorder in association
with an underlying systemic disease [11]. However, the
diagnosis is made after excluding other causes of ulcera-
tive skin lesions via histopathological findings. There is no
diagnostic laboratory test that is specific for PG. The
presence of neutrophils and increased ESR was observed in
most of the affected patients [12]. In our patient, we
made a diagnosis of pyoderma gangrenosum based on skin
histopathology. However, idiopathic pyoderma gan-
grenosum was suggested due to exclusion of other usual
associations.Figure 1 Abscess after healing forming an ulcer.Extracutaneous manifestation of PG in our patient was in
the form of splenic involvement. Allen CP et al reported a
child to have pyoderma gangrenosum with splenic and lung
involvement [13], and Johnson JL et al reported a child with
only splenic involvement [14]. There is limited data
regarding extracutaneous manifestation of PG in the pedi-
atric age group compared to adult patients, who frequently
report this comorbidity.
Patients with superficial pyoderma gangrenosum are
primarily treated with topical immunosuppressants (e.g.,
corticosteroids, calcineurin inhibitor, et al) whereas sys-
temic treatment requires systemic therapy such as corti-
costeroids and cyclosporine [15]. Alternative therapies
include dapsone, sulfapyridine, methotrexate, clofazimine,
minocycline, colchicine, intravenous immunoglobulins, and
anti-TNF agents [1]. This was described well in small un-
controlled studies and clinical experiences. Our patient
improved completely after administration of systemic
corticosteroid treatment, as observed by the rapid healing
of the ulcer, resolving of the fever, and disappearance of
the splenic abscess.
The number of pediatric patients with extracutaneous
manifestation of PG is limited. Further studies and
reports will enrich our knowledge in the clinical presen-
tation of this disease as well as guidelines for improved
management.
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